THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION

THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION

A method of improving the pharmacokinetics of VX-222 in a patient infected with HCV comprises co-administering VX-222 and VX-950 to the patient. A method of treating a patient infected with HCV comprises administering VX-222 and VX-950 to the patient, wherein VX-222 is in an amount of about 20 mg to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KOZIEL MARGARET JAMES, GEORGE SHELLEY, CHAURET NATHALIE, ROSARIO MARIA, NICOLAS OLIVIER, KIEFFER TARA LYNN, PROULX LOUISE
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KOZIEL MARGARET JAMES
GEORGE SHELLEY
CHAURET NATHALIE
ROSARIO MARIA
NICOLAS OLIVIER
KIEFFER TARA LYNN
PROULX LOUISE
description A method of improving the pharmacokinetics of VX-222 in a patient infected with HCV comprises co-administering VX-222 and VX-950 to the patient. A method of treating a patient infected with HCV comprises administering VX-222 and VX-950 to the patient, wherein VX-222 is in an amount of about 20 mg to about 400 mg, and wherein VX-950 is in an amount of about 100 mg to about 1,500 mg. A method of treating a patient infected with HCV comprises administering a therapeutically effective amount of VX-222, wherein VX-222 is administered at an amount of about 20 mg to about 2,000 mg once a day.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2013034522A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2013034522A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2013034522A13</originalsourceid><addsrcrecordid>eNrjZDAK8XANcgzwdA1WcPMPUggJcnUM8fRzV_BwDQAyQjyDFZwVwjyDQoMVPP3cXJ1DPP39eBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGhsYGxiamRkaOhMXGqAB5-J8k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION</title><source>esp@cenet</source><creator>KOZIEL MARGARET JAMES ; GEORGE SHELLEY ; CHAURET NATHALIE ; ROSARIO MARIA ; NICOLAS OLIVIER ; KIEFFER TARA LYNN ; PROULX LOUISE</creator><creatorcontrib>KOZIEL MARGARET JAMES ; GEORGE SHELLEY ; CHAURET NATHALIE ; ROSARIO MARIA ; NICOLAS OLIVIER ; KIEFFER TARA LYNN ; PROULX LOUISE</creatorcontrib><description>A method of improving the pharmacokinetics of VX-222 in a patient infected with HCV comprises co-administering VX-222 and VX-950 to the patient. A method of treating a patient infected with HCV comprises administering VX-222 and VX-950 to the patient, wherein VX-222 is in an amount of about 20 mg to about 400 mg, and wherein VX-950 is in an amount of about 100 mg to about 1,500 mg. A method of treating a patient infected with HCV comprises administering a therapeutically effective amount of VX-222, wherein VX-222 is administered at an amount of about 20 mg to about 2,000 mg once a day.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130207&amp;DB=EPODOC&amp;CC=US&amp;NR=2013034522A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130207&amp;DB=EPODOC&amp;CC=US&amp;NR=2013034522A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOZIEL MARGARET JAMES</creatorcontrib><creatorcontrib>GEORGE SHELLEY</creatorcontrib><creatorcontrib>CHAURET NATHALIE</creatorcontrib><creatorcontrib>ROSARIO MARIA</creatorcontrib><creatorcontrib>NICOLAS OLIVIER</creatorcontrib><creatorcontrib>KIEFFER TARA LYNN</creatorcontrib><creatorcontrib>PROULX LOUISE</creatorcontrib><title>THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION</title><description>A method of improving the pharmacokinetics of VX-222 in a patient infected with HCV comprises co-administering VX-222 and VX-950 to the patient. A method of treating a patient infected with HCV comprises administering VX-222 and VX-950 to the patient, wherein VX-222 is in an amount of about 20 mg to about 400 mg, and wherein VX-950 is in an amount of about 100 mg to about 1,500 mg. A method of treating a patient infected with HCV comprises administering a therapeutically effective amount of VX-222, wherein VX-222 is administered at an amount of about 20 mg to about 2,000 mg once a day.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAK8XANcgzwdA1WcPMPUggJcnUM8fRzV_BwDQAyQjyDFZwVwjyDQoMVPP3cXJ1DPP39eBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGhsYGxiamRkaOhMXGqAB5-J8k</recordid><startdate>20130207</startdate><enddate>20130207</enddate><creator>KOZIEL MARGARET JAMES</creator><creator>GEORGE SHELLEY</creator><creator>CHAURET NATHALIE</creator><creator>ROSARIO MARIA</creator><creator>NICOLAS OLIVIER</creator><creator>KIEFFER TARA LYNN</creator><creator>PROULX LOUISE</creator><scope>EVB</scope></search><sort><creationdate>20130207</creationdate><title>THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION</title><author>KOZIEL MARGARET JAMES ; GEORGE SHELLEY ; CHAURET NATHALIE ; ROSARIO MARIA ; NICOLAS OLIVIER ; KIEFFER TARA LYNN ; PROULX LOUISE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2013034522A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KOZIEL MARGARET JAMES</creatorcontrib><creatorcontrib>GEORGE SHELLEY</creatorcontrib><creatorcontrib>CHAURET NATHALIE</creatorcontrib><creatorcontrib>ROSARIO MARIA</creatorcontrib><creatorcontrib>NICOLAS OLIVIER</creatorcontrib><creatorcontrib>KIEFFER TARA LYNN</creatorcontrib><creatorcontrib>PROULX LOUISE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOZIEL MARGARET JAMES</au><au>GEORGE SHELLEY</au><au>CHAURET NATHALIE</au><au>ROSARIO MARIA</au><au>NICOLAS OLIVIER</au><au>KIEFFER TARA LYNN</au><au>PROULX LOUISE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION</title><date>2013-02-07</date><risdate>2013</risdate><abstract>A method of improving the pharmacokinetics of VX-222 in a patient infected with HCV comprises co-administering VX-222 and VX-950 to the patient. A method of treating a patient infected with HCV comprises administering VX-222 and VX-950 to the patient, wherein VX-222 is in an amount of about 20 mg to about 400 mg, and wherein VX-950 is in an amount of about 100 mg to about 1,500 mg. A method of treating a patient infected with HCV comprises administering a therapeutically effective amount of VX-222, wherein VX-222 is administered at an amount of about 20 mg to about 2,000 mg once a day.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2013034522A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A47%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOZIEL%20MARGARET%20JAMES&rft.date=2013-02-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2013034522A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true